GlobalSpace Technologies announces launch of PATGPT

GlobalSpace Technologies Ltd announces the launch of PATGPT, a Pharma-specific Large Language Model (LLM) platform. PATGPT will operate under a hybrid model where 50% of the model training is already done by GlobalSpace on pharmaceutical datasets, and the remaining 50% will be trained using proprietary datasets of pharmaceutical companies within their own secure cloud environments.

This dual approach positions PATGPT as both a product and a customized LLM training service, enabling pharma companies to securely build organization-specific AI intelligence. In its initial phase, PATGPT will focus on sales, marketing, inventory, and distribution optimization. The future roadmap includes applications in R&D, clinical trials, pharmacovigilance, and regulatory submissions.

Shares of Globalspace Technologies Ltd was last trading in BSE at Rs. 15.66 as compared to the previous close of Rs. 15.40. The total number of shares traded during the day was 2694 in over 39 trades.

The stock hit an intraday high of Rs. 15.89 and intraday low of 15.21. The net turnover during the day was Rs. 41509.00.

Source : Equity Bulls

Keywords

GlobalspaceTechnologies INE632W01016 PATGPT PharmaSpecific LLM